160 related articles for article (PubMed ID: 27347132)
1. Expression and clinical significance of glucose transporter-1 in pancreatic cancer.
Lu K; Yang J; Li DC; He SB; Zhu DM; Zhang LF; Zhang XU; Chen XC; Zhang B; Zhou J
Oncol Lett; 2016 Jul; 12(1):243-249. PubMed ID: 27347132
[TBL] [Abstract][Full Text] [Related]
2. Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer.
Chikamoto A; Inoue R; Komohara Y; Sakamaki K; Hashimoto D; Shiraishi S; Takamori H; Yamashita YI; Yoshida N; Yamanaka T; Yamashita Y; Baba H
Ann Surg Oncol; 2017 Jul; 24(7):2040-2046. PubMed ID: 28180987
[TBL] [Abstract][Full Text] [Related]
3. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
[TBL] [Abstract][Full Text] [Related]
4. Relationship between clinicopathological factors and fluorine-18-fluorodeoxyglucose uptake in patients with papillary thyroid cancer.
Kaida H; Hiromatsu Y; Kurata S; Kawahara A; Hattori S; Taira T; Kobayashi M; Uchida M; Yamada K; Mihashi H; Umeno H; Kage M; Nakashima T; Hayabuchi N; Ishibashi M
Nucl Med Commun; 2011 Aug; 32(8):690-8. PubMed ID: 21606885
[TBL] [Abstract][Full Text] [Related]
5. Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma.
Park SG; Lee JH; Lee WA; Han KM
Nucl Med Biol; 2012 Nov; 39(8):1167-72. PubMed ID: 22901702
[TBL] [Abstract][Full Text] [Related]
6. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.
Higashi T; Tamaki N; Torizuka T; Nakamoto Y; Sakahara H; Kimura T; Honda T; Inokuma T; Katsushima S; Ohshio G; Imamura M; Konishi J
J Nucl Med; 1998 Oct; 39(10):1727-35. PubMed ID: 9776278
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of glucose transporter protein-1 overexpression in human osteosarcoma.
Fan J; Mei J; Zhang MZ; Yuan F; Li SZ; Yu GR; Chen LH; Tang Q; Xian CJ
Oncol Lett; 2017 Aug; 14(2):2439-2445. PubMed ID: 28781680
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
Yen TC; See LC; Lai CH; Yah-Huei CW; Ng KK; Ma SY; Lin WJ; Chen JT; Chen WJ; Lai CR; Hsueh S
J Nucl Med; 2004 Jan; 45(1):22-9. PubMed ID: 14734665
[TBL] [Abstract][Full Text] [Related]
9. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.
Higashi T; Tamaki N; Honda T; Torizuka T; Kimura T; Inokuma T; Ohshio G; Hosotani R; Imamura M; Konishi J
J Nucl Med; 1997 Sep; 38(9):1337-44. PubMed ID: 9293783
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.
Reske SN; Grillenberger KG; Glatting G; Port M; Hildebrandt M; Gansauge F; Beger HG
J Nucl Med; 1997 Sep; 38(9):1344-8. PubMed ID: 9293784
[TBL] [Abstract][Full Text] [Related]
11. Expression of glucose transporter-1 is correlated with hypoxia-inducible factor 1α and malignant potential in pancreatic neuroendocrine tumors.
Fujino M; Aishima S; Shindo K; Oda Y; Morimatsu K; Tsutsumi K; Otsuka T; Tanaka M; Oda Y
Oncol Lett; 2016 Nov; 12(5):3337-3343. PubMed ID: 27900001
[TBL] [Abstract][Full Text] [Related]
12. Expression of Glut-1 and HK-II in Pancreatic Cancer and Their Impact on Prognosis and FDG Accumulation.
Yang HJ; Xu WJ; Guan YH; Zhang HW; Ding WQ; Rong L; Qiu ZB; Zhong L
Transl Oncol; 2016 Dec; 9(6):583-591. PubMed ID: 27916293
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer.
Schreurs LM; Smit JK; Pavlov K; Pultrum BB; Pruim J; Groen H; Hollema H; Plukker JT
Ann Surg Oncol; 2014 Nov; 21(12):3751-7. PubMed ID: 24939624
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of
Zheng H; Cui Y; Li X; Du B; Li Y
Clin Lung Cancer; 2019 Nov; 20(6):420-428. PubMed ID: 31300363
[TBL] [Abstract][Full Text] [Related]
15. Molecular biological correlation of fluorine-18 fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
Hirose Y; Kaida H; Kawahara A; Matono S; Tanaka T; Kurata S; Kage M; Ishibashi M; Abe T
Nucl Med Commun; 2016 Oct; 37(10):1053-61. PubMed ID: 27218430
[TBL] [Abstract][Full Text] [Related]
16. FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
Nguyen XC; Lee WW; Chung JH; Park SY; Sung SW; Kim YK; So Y; Lee DS; Chung JK; Lee MC; Kim SE
Eur J Radiol; 2007 May; 62(2):214-9. PubMed ID: 17239556
[TBL] [Abstract][Full Text] [Related]
17. Correlations between dual-phase 18F-FDG uptake and clinicopathologic and biological markers of breast cancer.
Kaida H; Azuma K; Toh U; Kawahara A; Sadashima E; Hattori S; Akiba J; Tahara N; Rominger A; Ishii K; Murakami T; Ishibashi M
Hell J Nucl Med; 2018; 21(1):35-42. PubMed ID: 29550845
[TBL] [Abstract][Full Text] [Related]
18. The difference in relationship between 18F-FDG uptake and clinicopathological factors on thyroid, esophageal, and lung cancers.
Kaida H; Kawahara A; Hayakawa M; Hattori S; Kurata S; Fujimoto K; Azuma K; Hirose Y; Takamori S; Hiromatsu Y; Nakashima T; Fujita H; Kage M; Hayabuchi N; Ishibashi M
Nucl Med Commun; 2014 Jan; 35(1):36-43. PubMed ID: 24169686
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the association between HIF-1α and HER-2 expression, hormone receptor status, Ki-67 expression, histology and tumor FDG uptake in breast cancer.
Cerci SM; Bozkurt KK; Eroglu HE; Cerci C; Erdemoglu E; Bulbul PT; Cetin M; Cetin R; Ciris IM; Bulbul M
Oncol Lett; 2016 Nov; 12(5):3889-3895. PubMed ID: 27895745
[TBL] [Abstract][Full Text] [Related]
20. Comparison of GLUT-1, SGLT-1, and SGLT-2 expression in false-negative and true-positive lymph nodes during the
Taira N; Atsumi E; Nakachi S; Takamatsu R; Yohena T; Kawasaki H; Kawabata T; Yoshimi N
Lung Cancer; 2018 Sep; 123():30-35. PubMed ID: 30089592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
